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We present an analysis of strain and patient factors
associated with the development of bloody diarrhea and
hemolytic uremic syndrome (HUS) among Shiga toxin–pro-
ducing  Escherichia coli (STEC) patients registered in
Denmark in a 6-year period. Of 343 STEC patients, bloody
diarrhea developed in 36.4% and HUS in 6.1%. In a multi-
variate logistic regression model, risk factors for bloody
diarrhea were the eae and stx2 genes, O groups O157 and
O103, and increasing age. Risk factors for HUS were pres-
ence of the stx2 (odds ratio [OR] 18.9) and eae (OR unde-
fined) genes, being a child, and having bloody diarrhea. O
group O157, although associated with HUS in a univariate
analysis (OR 4.0), was not associated in the multivariate
analysis (OR 1.1). This finding indicates that, rather than
the O group, the combined presence of the eae and stx2
genes is an important predictor of HUS.
S
higa toxin–producing Escherichia coli (STEC), alter-
natively known as verocytotoxin–producing E. coli, is
a major cause of gastroenteritis in developed countries (1).
Symptoms range from mild to severe gastroenteritis with
bloody diarrhea, and the infection may be complicated
with hemolytic uremic syndrome (HUS) (1). STEC strains
are defined by the Shiga (Stx) toxins; two classes, Stx1 and
Stx2, are recognized (2). STEC strains also frequently har-
bor the locus of enterocyte effacement (LEE) pathogenici-
ty island, which encodes intimin and a number of other
virulence factors responsible for the intestinal attaching
and effacing lesions (2). Several other factors may be
involved in the pathogenic process, among them the
enterohemolysin produced by many STEC strains (2). In
several regions of the world, STEC strains of O group
O157 are isolated from most patients, but STEC strains
may belong to a large number of other O groups (2,3).
Only a few epidemiologic studies have addressed the
relative importance of virulence factors for serious clinical
disease. We studied a cohort of Danish STEC patients and
determined risk factors for HUS and bloody diarrhea
among a series of microbiologic and patient-related char-
acteristics.
Materials and Methods
Patients and Isolates
From January 1, 1997, to May 1, 2003, 425 patients
with STEC infections were registered in Denmark, a coun-
try of 5.4 million. These 425 registrations comprised the
instances in which an STEC strain had been isolated from
a fecal specimen obtained from a patient. In Denmark,
clinical specimens for analysis for bacterial gastrointesti-
nal pathogens are submitted to the Statens Serum Institut
(SSI) or to 1 of 10 regional clinical microbiologic labora-
tories, depending on the county in which the physician
who requests the analysis resides. In most patients (92%),
infections were diagnosed from specimens sent to SSI,
where the screening procedure was based on presence of
the stx genes. Briefly, the diagnostic procedure consisted
of isolating bacterial strains by using the SSI enteric media
(4) and screening colonies with an E. coli morphology for
stx genes by using colony hybridization with pooled DNA
polynucleotide probes.
Subsequently, all isolates were referred to the national
reference laboratory at SSI, and the STEC diagnosis was
verified by using the Vero cell assay (5). The isolates were
then further characterized for reference purposes. This
process included full O:H serotyping (6) and determining
the presence of the stx1, stx2, eae (intimin encoding), and
ehxA (enterohemolysin encoding) virulence genes by
hybridization to individual DNA polynucleotide probes.
Patient Interviews
Starting January 1, 1997, STEC patients registered in
Denmark have been routinely interviewed by physicians at
the Department of Gastrointestinal Infections at SSI. This
practice was initiated to identify possible outbreaks and to
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Copenhagen, Denmark obtain data on the basic manifestations of disease and
routes of infection. The patients (or their parents) were
contacted by phone and interviewed by using a concise
questionnaire. The questions concerned information on
signs and symptoms, treatment, travel, contact with ani-
mals and other persons with similar symptoms, and
whether the person, before becoming ill, had consumed
items from a short list of foodstuffs and drinks that might
potentially be associated with STEC infections. These
interviews were the prime source of deciding whether the
patients had HUS or bloody diarrhea, although for some
patients, information from the requesting physicians was
also obtained.
Patient Data 
Atotal of 82 patients were excluded from the cohort for
various reasons. The isolates from 11 patients were not
fully characterized with regard to virulence factors. For
another 62 patients, details from interviews were insuffi-
cient, usually because patients could not be contacted by
phone or because of language difficulties. Finally, two dif-
ferent STEC strains of different O groups were found in
the fecal samples of nine patients. These strains were
excluded because determining which isolate was responsi-
ble for the clinical symptoms was not possible. Among
these nine patients were two with HUS. These were girls,
ages l and 2 years, one of whom had bloody diarrhea. The
girls were infected with isolates of O groups O145 and
O156, and O groups O21 and O145, respectively. All four
strains were eae-positive, stx1-negative, and stx2-positive. 
Thus, the dataset used in the present analyses contained
343 patients. Nearly all of the illnesses were sporadic since
no general outbreaks occurred in Denmark within the
study period. A few patients may have been epidemiologi-
cally linked, however, by belonging to the same family or
attending the same school or kindergarten.
The dataset was analyzed with respect to the two types
of clinical outcomes, HUS and bloody diarrhea, by using a
set of possible and available explanatory variables consist-
ing of both microbiologic and patient factors. The micro-
biologic factors were O group and the absence or presence
of each of the eae, stx1, stx2, and ehxA genes. By definition
all isolates contained one or both of the stx1 and stx2 genes.
The patient factors were age and gender; whether the
patient had been hospitalized; diarrhea; bloody diarrhea
(when analyzing for HUS); fever; vomiting; abdominal
pain or joint pains; whether the patients had received anti-
mobility agents or antimicrobial agents as a result of the
infection; acquisition of the infection abroad; patient con-
tact with other persons with similar symptoms or with ani-
mals (and if so which animals); and whether or not the
patient, in the 5 days before symptoms developed, had
eaten at a restaurant or consumed beef, lamb, pork, poul-
try, bean sprouts, unpasteurized milk, apple juice, or
unwashed raw vegetables.
Statistical Analyses
The statistical analyses were performed by using the
SAS statistical package (Cary, NC). Variables were consid-
ered in a logistic regression analysis on the basis of statis-
tical significance in a univariate analysis and biological
relevance. Variables were subsequently eliminated from
the logistic regression models if they were not significant
at the 5% level or not confounding other explanatory vari-
ables; competing models were compared with likelihood
ratio testing. Finally, the models were examined for statis-
tical interactions, and odds ratios (ORs) with 95% confi-
dence intervals (CIs) were calculated.
All variables were dichotomous, except age. While the
age distribution for the whole group of STEC patients and
for patients with bloody diarrhea was only slightly skewed
towards younger age groups, the HUS patients were
young; of the 21 HUS patients, 18 were <8 years of age.
For this reason, age was entered as an interval scale vari-
able in the model for bloody diarrhea but as a dichotomous
variable in the model for HUS, comparing the patients
aged >8 years to those <7 years.
Results
The cohort consisted of 343 patients; HUS had devel-
oped in 21 (6.1%), and bloody diarrhea had occurred in
125 (36.4%). The isolates comprised 74 serotypes and 49
different O groups. Among the O groups, O157 was the
most common, comprising 81 (23.6%) isolates followed
by O26 with 50 (14.6%) isolates and O103 with 45
(13.1%) isolates. A total of 30 different O groups occurred
only once. Table 1 summarizes the O groups and the occur-
rence of HUS, bloody diarrhea, virulence genes, and medi-
an age of patients within the O groups. Of the patients,
32.2% had been hospitalized, 16.2% had received
antibimicrobial treatment, and 16.4% had received treat-
ment with antimobility agents as a result of the STEC
infection; 22.0% reported having been infected on foreign
travel.
HUS
Among the 21 strains isolated from HUS patients, 11
were O group O157; 3 were O26; 2 were O111; and 1 each
was O103, O121, O137, O145, and O165. Of the O157
strains, nine were O157:H7 and two O157:H-. All of the 21
strains were positive for the eae gene, while 18 strains
were stx2-positive, 1 strain stx1-positive, and 2 strains stx1-
and stx2-positive. Eighteen of the patients were <7 years of
age. Table 2 shows the occurrence of bloody diarrhea, vir-
ulence genes, and median age of the patients within the O
groups of the isolates from the 21 HUS patients.
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were calculated. On the basis of the possible determinants
that were significantly associated with HUS within 90%
confidence limits, a multivariate logistic regression model
for HUS development was built. Because all strains from
HUS case-patients contained the eae gene, the OR of this
determinant could not be estimated, and the final model
contained just three determinants: presence of the stx2
gene, bloody diarrhea, and age of <7 years. No statistical
interaction was detected in the model. The details of the
results of the univariate and multivariate analyses of the
odds of developing HUS are shown in Table 3. Notably, O
group O157, though significant in the univariate analysis,
was not a risk factor. The OR for O157 declined from 4.0
(95% CI 1.6 to 9.7) to 1.1 (95% CI 0.4 to 3.1) when the
other factors were included in the model. Of the other pre-
dictors, O group O111 was also associated with an
increased risk for HUS in the univariate analysis but not in
the multivariate analysis (Table 3).
Eight of the HUS patients and 43 of the non-HUS
patients had received antimicrobial treatment during the
course of the STEC infection, and in fact the variable of
being treated with antimicrobial agents as a result of the
infection was also associated with an increased risk for
HUS in a univariate analysis (OR 3.6; 95% CI 1.4 to 9.1)
and when included in the multivariate analysis (OR 4.8;
95% CI 1.4 to 16.2). However, the antimicrobial treatment
status was unknown for 29 of the non-HUS patients, so
they were excluded from the analysis when the variable
was included. The variable did not confound or interact
with the three other determinants when added to the
model.
The two remaining microbiologic traits, presence of the
stx1 gene and the ehxA gene, were not associated with an
increased risk for HUS in the univariate or multivariate
analyses. Apart from the fact that all HUS patients had
been hospitalized, the remaining available patient charac-
teristics (i.e., sex, foreign travel, other symptoms apart
from bloody diarrhea, contact with animals or other ill per-
sons, and the food and drink exposures) were also not
associated with increased risk for HUS. 
Bloody Diarrhea
An analysis was also made of risk factors for bloody
diarrhea. On the basis of the patient interviews and the
available clinical information, 125 patients with bloody
diarrhea were identified. Of the strains isolated from these
patients, 86% contained the eae gene and 67% the stx2
gene; 45% of the strains belonged to O group O157 and
17% to O group O103. 
Again, ORs for each of the available putative determi-
nants were calculated, and a logistic regression model was
developed on the basis thereof. The final model contained
the following five variables: eae-positive, stx2-positive, O
group O157, O group O103, and age. Age was incorporat-
ed as an interval scale variable. The modeling indicated
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Table 1. Number of isolates, clinical outcome, virulence factors, and median age for the O groups of STEC patients, Denmark
a 
O group  No. of isolates  HUS  Bloody diarrhea  eae-positive  stx1-positive  stx2-positive  ehxA-positive  Median age 
O157  81  11  56  80  31  81  80  12 
O26  50  3  16  50  42  12  45  1 
O103  45  1  21  44  45  0  44  4 
Other
b  30  2  8  12  17  17  12  8 
O rough  21  0  4  4  16  15  14  28 
O117  19  0  1  0  19  0  1  32 
O145  18  1  5  17  7  11  18  3 
O146  18  0  4  0  13  15  11  48 
O121  9  1  3  9  0  9  9  1 
O91  7  0  0  0  6  5  4  25 
O nontypeable  7  0  0  1  4  3  3  25 
O111  6  2  2  6  6  3  5  1 
O128  6  0  0  0  6  5  5  31 
O156  5  0  0  2  5  0  2  32 
O55  4  0  1  2  4  0  0  3 
O15  3  0  1  0  0  3  1  21 
O70  3  0  0  3  2  1  3  1 
O174  3  0  2  0  2  2  2  36 
O5  2  0  1  1  2  0  2  30 
O41  2  0  0  1  2  0  0  40 
O76  2  0  0  0  2  0  1  42 
O88  2  0  0  0  1  2  2  39 
All  343  21  125  232  232  184  264  12 
aSTEC, Shiga toxin–producing Escherichia coli; HUS, hemolytic uremic syndrome. 
bIncludes all O groups that contained one isolate only. that all the above-mentioned variables were associated
with an increased risk for bloody diarrhea (Table 4).
Presence of the eae gene was the virulence factor that
showed the closest association with development of
bloody diarrhea, whereas the effect of presence of the stx2
gene was more modest. In contrast to what was found
regarding HUS, O group O157 and O103 were independ-
ent risk factors for bloody diarrhea. In addition, there was
statistical interaction (p = 0.03) between the determinants
eae-positive and O group O103. However, only one O103
strain was eae-negative, and on this basis we choose to
ignore this interaction.
Age was found to be a risk factor for bloody diarrhea,
but the risk increased with age as opposed to what was
found for HUS patients (Table 4). In addition, there was an
association (multivariate OR 2.2; 95% CI 1.1 to 5.0)
between bloody diarrhea and indigenous infection (i.e., not
infected while traveling abroad), although the status of this
variable was unknown in 14 instances (data not shown).
Finally, 29 of 117 bloody diarrhea patients and 22 of 197
nonbloody diarrhea patients had received antimicrobial
treatment as a result of the STEC infection and, as for the
analysis for HUS, the OR of antimicrobial treatment could
be estimated after reducing the dataset by 29 cases. The
univariate OR was 2.6 (95% CI 1.4 to 4.8), and upon inclu-
sion of this variable in the logistic regression model, the
multivariate OR was 3.0 (95% CI 1.4 to 6.3).
Virulence factors not associated with increased odds of
bloody diarrhea included presence of the stx1 gene (not
shown) and presence of the ehxA gene, although the latter,
on the basis of the univariate analysis alone, was included
as a risk factor (Table 4). The OR for presence of the ehxA
gene was 0.9 (95% CI 0.4 to 1.9) when this variable was
included in the model. None of the remaining patient char-
acteristics was associated with bloody diarrhea in the mul-
tivariate analysis, although two symptoms were associated
in the univariate analysis, namely fever (OR 1.8; 95% CI
1.1 to 2.9) and abdominal pains (OR 2.6; 95% CI 1.4 to
4.9). In addition, bloody diarrhea conferred an increased
risk for hospitalization (OR 6.7; 95% CI 4.0 to 11.3).
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Table 2. Number of isolates, instances of bloody diarrhea, virulence factors, and median age for O groups among 21 patients with 
hemolytic uremic syndrome 
O group  No. of isolates  Bloody diarrhea  eae- positive  stx1-positive  stx2-positive  ehxA-positive  Median age 
O157  11  8  11  0  11  10  4 
O26  3  2  3  0  3  2  1 
O111  2  2  2  2  2  1  1 
O103  1  1  1  1  0  1  1 
O121  1  0  1  0  1  1  1 
O137  1  0  1  0  1  1  3 
O145  1  1  1  0  1  1  2 
O165  1  1  1  0  1  0  0 
All  21  15  21  3  20  17  1 
Table 3. Risk factors for HUS among 343 STEC patients, Denmark, 1997–2003
a 
    Univariate analysis  Multivariate analysis 
Determinant  No. of patients  No. (%) with HUS   OR  95% CI  OR  95% CI 
eae 
Negative  111  0  1       
Positive  232  21 (9.1)  ND
b    NI   
stx2 
Negative  159  1 (0.6)  1    1   
Positive  184  20 (10.9)  19.3  2.6 to 145  18.9  2.4 to 146 
Age 
>8 y  178  3 (1.7)  1    1   
<7 y  165  18 (10.9)  7.5  2.2 to 26.0  11.4  3.2 to 41.3 
Bloody diarrhea 
No  218  6 (2.8)  1    1   
Yes  125  15 (12.0)  4.8  1.8 to 12.8  4.5  1.6 to 12.7 
O157 
No  262  10 (3.8)  1       
Yes  81  11 (13.6)  4.0  1.6 to 9.7  NS   
O111 
No  337  19 (5.6)  1       
Yes  6  2 (33.3)  8.4  1.4 to 48.6  NS   
aSTEC, Shiga toxin–producing Escherichia coli; HUS, hemolytic uremic syndrome; OR, odds ratio; CI, confidence intervals; NI, not included (test not appropriate); ND, 
not defined; NS, not statistically significant. 
bp < 0.0002, Fisher exact test. Discussion
This study presents an analysis of determinants of seri-
ous clinical disease among Danish STEC patients during a
period of 6.33 years. The dataset we used stems from a full
national cohort of largely sporadic cases. The strains have
been collected and the patients interviewed prospectively.
Furthermore, for >90% of the strains, the diagnostic
screening methods have been based on presence of the stx
genes, the very feature that distinguishes STEC from other
E. coli. The dataset is therefore largely free of several types
of otherwise common biases, such as those that may poten-
tially arise through the process of selecting strains from
strain collections, from studying outbreak strains, through
missing patient information, or through surveillance
directed towards certain serotypes such as O157:H7. For
these reasons we find this dataset, although relatively
small, to be well suited for an analysis of the impact of
basic patient characteristics and virulence factors—in par-
ticular, the significance of different serotypes or O
groups—on serious disease. 
However, the limitations of the dataset should also be
kept in mind. Among these is the relatively small number of
available explanatory variables. At present, we have data on
only a small series of virulence genes and no information
on subtypes of individual genes. Also, the basic nature of
the available patient information does not permit any type
of detailed analysis of many patient-related factors that may
play a role in the development of serious symptoms.
More than three quarters of the patients and roughly
half of those complicated with HUS were infected with
non-O157 STEC strains. The determinants associated with
the development of HUS were the stx2 gene, the eae gene
(indicating the presence of the LEE pathogenicity island),
and young age. In addition, bloody diarrhea and treatment
with antimicrobial agents were independently associated
with HUS. O group O157 was not associated with an
increased risk for HUS when we controlled for the pres-
ence of the stx2 gene. The apparent association with O157
seen in the univariate analysis was primarily due to the fact
that all the O157 isolates contained the stx2 gene. Thus, our
findings indicate that the potential of E. coli O157 strains
to cause HUS may by and large be explained by the fact
that these strains almost invariably encode Stx2 and the
virulence factors of the LEE pathogenicity island.
The association between HUS and the eae gene, the stx2
gene, or both, has been observed in several other epidemi-
ologic studies (7–10), although to our knowledge only one
has been based on multivariate modeling (11). Although
the approach taken in that study was somewhat different
from ours, the conclusions were in line with ours; the
authors found that, of a series of virulence genes including
the ehxA gene, the eae and stx2 genes were the only signif-
icant determinants of HUS. Two other recent studies also
point to the association between the eae and stx2 genes and
the development of HUS. One compares virulence genes
in non-O157 STEC strains from HUS patients with those
from other infected persons in the United Kingdom (12);
the other compares the frequency with which the two
genes and the various O groups occur among German
STEC patients with and without HUS (13).
In the analysis for bloody diarrhea, the determinants we
found were, again, presence of the eae and  stx2 genes,
although the stx2 association was much less pronounced. In
addition, the two most frequently occurring O groups,
O157 and O103, were independent determinants. The lat-
ter finding indicates that additional virulence factors
RESEARCH
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Table 4. Risk factors for bloody diarrhea among 343 STEC patients, Denmark, 1997–2003  
    Univariate analysis  Multivariate analysis 
Determinant  No. of patients  No. (%) with BD  OR  95% CI  OR  95% CI 
eae 
Negative  111  17 (15.3)  1    1   
Positive  232  108 (46.6)  4.8  2.7 to 8.6  6.0  2.7 to 13.3 
stx2 
Negative  159  41 (25.8)  1    1   
Positive  184  84 (45.7)  2.4  1.5 to 3.8  2.5  1.2 to 5.1 
O157 
No  262  69 (26.3)  1    1   
Yes  81  56 (69.1)  6.3  3.6 to 10.8  2.7  1.2 to 5.7 
O103 
No  298  104 (34.9)  1    1   
Yes  45  21 (46.7)  1.6  0.9 to 3.1  2.8  1.2 to 6.3 
ehxA 
No  79  15 (19.0)  1       
Yes  264  110 (41.7)  3.0  1.7 to 5.6  NS   
Age
b  –  –  –  –  1.3  1.2 to 1.5 
aSTEC, Shiga toxin–producing Escherichia coli; BD, bloody diarrhea; OR, odds ratio; CI, confidence intervals; NS, not statistically significant. 
bCalculated for an increase in age of 10 years. important for inducing bloody diarrhea may be present
among isolates of these two O groups. Since bloody diar-
rhea was a risk factor in the analysis for HUS, this may
also be of some importance for the development of HUS.
We note that the single stx2-negative STEC strain isolated
from an HUS patient was of O group O103. 
In concordance with the findings of others (2), our
results do not indicate that the ehxA gene plays an inde-
pendent role in the pathogenic process leading to HUS or
bloody diarrhea. The ehxA gene was not associated with
HUS and although, on the basis of the univariate analysis,
it appeared to be associated with bloody diarrhea, this
association was no longer present in the multivariate
analysis, i.e., after controlling for the determinants present
in the model for bloody diarrhea.
Treatment with antimicrobial agents was a risk factor
for both HUS and bloody diarrhea. This finding is of inter-
est in light of the ongoing discussion of whether or not cer-
tain antimicrobial agents have the potential to induce
serious clinical symptoms including HUS among patients
with STEC infections (14). However, our data do not have
sufficient clinical detail to determine the causal direction
of this finding. Patients with HUS or bloody diarrhea ini-
tially have more severe symptoms than other STEC
patients and may be more likely to receive antimicrobial
treatment. Therefore, we may be observing a selection for
more severe symptoms and not an effect of the antimicro-
bial agents per se.
Finally, we note that although only 9 patients out of the
full cohort of 425 patients had two different STEC isolates
simultaneously recovered from their stools, these 9 patients
comprised 2 of the 23 HUS patients known to be present
within the cohort. In both instances, both isolates were eae-
and stx2-positive. This finding raises the possibility that dif-
ferent STEC isolates may complement each other in the
pathogenic process leading to HUS and that such synergy
may lead to an increased risk of developing HUS.
To conclude, our analyses indicate that the determi-
nants associated with development of HUS are presence of
the eae gene, presence of the stx2 gene, being a young
child, and bloody diarrhea. Our analyses also indicate that
the combined presence of the eae and stx2 genes is a better
marker for the potential to cause HUS than is O group
O157. This finding may have implications for the future
planning of improved diagnostics and surveillance of
STEC infections.
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